 Marcelo Perraillon
Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicare | 19 | 2026 | 907 | 4.330 |
Why?
| | Early Detection of Cancer | 4 | 2026 | 501 | 1.830 |
Why?
| | Nursing Homes | 5 | 2019 | 171 | 1.270 |
Why?
| | Dementia | 4 | 2022 | 322 | 1.160 |
Why?
| | Preventive Health Services | 2 | 2023 | 154 | 1.150 |
Why?
| | Fee-for-Service Plans | 5 | 2023 | 98 | 1.150 |
Why?
| | Insurance Claim Review | 3 | 2026 | 85 | 1.110 |
Why?
| | Mass Screening | 3 | 2026 | 1300 | 1.100 |
Why?
| | Medicaid | 6 | 2026 | 472 | 1.090 |
Why?
| | United States | 38 | 2026 | 16041 | 1.070 |
Why?
| | Medicare Part C | 2 | 2025 | 38 | 1.020 |
Why?
| | Lung Neoplasms | 4 | 2025 | 2674 | 0.990 |
Why?
| | Cost Sharing | 1 | 2026 | 23 | 0.930 |
Why?
| | Neoplasms | 6 | 2025 | 2944 | 0.930 |
Why?
| | Depression, Postpartum | 2 | 2025 | 116 | 0.920 |
Why?
| | SEER Program | 2 | 2024 | 233 | 0.910 |
Why?
| | Patient Acceptance of Health Care | 2 | 2025 | 880 | 0.900 |
Why?
| | Fathers | 1 | 2025 | 53 | 0.850 |
Why?
| | Colorado | 12 | 2026 | 4588 | 0.840 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2025 | 1194 | 0.790 |
Why?
| | Aged | 30 | 2026 | 26251 | 0.780 |
Why?
| | Registries | 8 | 2026 | 2382 | 0.780 |
Why?
| | Drug Costs | 2 | 2025 | 115 | 0.770 |
Why?
| | Insurance, Health | 1 | 2026 | 315 | 0.760 |
Why?
| | Comparative Effectiveness Research | 1 | 2023 | 170 | 0.700 |
Why?
| | Information Dissemination | 2 | 2022 | 224 | 0.690 |
Why?
| | Antineoplastic Agents | 2 | 2025 | 2218 | 0.670 |
Why?
| | Medical Record Linkage | 1 | 2021 | 68 | 0.660 |
Why?
| | Aged, 80 and over | 18 | 2025 | 8351 | 0.660 |
Why?
| | Mental Status and Dementia Tests | 1 | 2021 | 28 | 0.650 |
Why?
| | Breast Neoplasms | 2 | 2024 | 2411 | 0.640 |
Why?
| | Preventive Medicine | 1 | 2019 | 38 | 0.590 |
Why?
| | Insurance Coverage | 4 | 2023 | 246 | 0.590 |
Why?
| | Prostatic Neoplasms | 1 | 2026 | 972 | 0.560 |
Why?
| | Mothers | 1 | 2025 | 771 | 0.550 |
Why?
| | Research | 1 | 2022 | 421 | 0.550 |
Why?
| | Nootropic Agents | 1 | 2018 | 30 | 0.550 |
Why?
| | Medicare Part D | 1 | 2018 | 23 | 0.550 |
Why?
| | Health Facility Administrators | 1 | 2017 | 6 | 0.520 |
Why?
| | Quality Indicators, Health Care | 2 | 2017 | 340 | 0.520 |
Why?
| | Humans | 53 | 2026 | 145625 | 0.510 |
Why?
| | Female | 36 | 2026 | 79080 | 0.470 |
Why?
| | Pneumonia | 4 | 2013 | 633 | 0.470 |
Why?
| | Homes for the Aged | 1 | 2016 | 30 | 0.460 |
Why?
| | Skilled Nursing Facilities | 4 | 2022 | 152 | 0.450 |
Why?
| | Male | 31 | 2026 | 73014 | 0.440 |
Why?
| | Healthcare Disparities | 3 | 2026 | 728 | 0.440 |
Why?
| | Depression | 1 | 2025 | 1566 | 0.430 |
Why?
| | Clinical Coding | 2 | 2013 | 28 | 0.390 |
Why?
| | Stroke | 4 | 2026 | 1283 | 0.370 |
Why?
| | Databases, Factual | 5 | 2026 | 1481 | 0.360 |
Why?
| | Health Expenditures | 2 | 2026 | 196 | 0.360 |
Why?
| | Internet | 1 | 2016 | 656 | 0.340 |
Why?
| | Antidepressive Agents | 2 | 2014 | 234 | 0.300 |
Why?
| | Hospitalization | 6 | 2025 | 2468 | 0.300 |
Why?
| | Retrospective Studies | 12 | 2025 | 17291 | 0.270 |
Why?
| | Health Care Costs | 3 | 2022 | 418 | 0.260 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1403 | 0.250 |
Why?
| | Risk Factors | 8 | 2026 | 10840 | 0.240 |
Why?
| | Middle Aged | 13 | 2026 | 36359 | 0.230 |
Why?
| | Socioeconomic Factors | 3 | 2018 | 1323 | 0.220 |
Why?
| | Cohort Studies | 3 | 2025 | 6045 | 0.210 |
Why?
| | Community-Acquired Infections | 3 | 2013 | 179 | 0.210 |
Why?
| | Communication Barriers | 1 | 2026 | 129 | 0.210 |
Why?
| | Heart Failure | 4 | 2022 | 2323 | 0.210 |
Why?
| | Long-Term Care | 1 | 2015 | 116 | 0.210 |
Why?
| | Patient Navigation | 1 | 2026 | 126 | 0.200 |
Why?
| | Patient Readmission | 3 | 2023 | 771 | 0.200 |
Why?
| | Patient Discharge | 4 | 2023 | 991 | 0.200 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2022 | 104 | 0.200 |
Why?
| | Early Medical Intervention | 1 | 2024 | 59 | 0.190 |
Why?
| | Young Adult | 6 | 2026 | 14240 | 0.190 |
Why?
| | Time-to-Treatment | 1 | 2025 | 257 | 0.190 |
Why?
| | Hospice Care | 2 | 2024 | 230 | 0.190 |
Why?
| | Health Surveys | 1 | 2015 | 511 | 0.190 |
Why?
| | Self-Injurious Behavior | 1 | 2014 | 128 | 0.190 |
Why?
| | Mammography | 1 | 2024 | 172 | 0.190 |
Why?
| | Diabetes Complications | 2 | 2021 | 219 | 0.180 |
Why?
| | Interviews as Topic | 2 | 2017 | 926 | 0.180 |
Why?
| | Hormones | 1 | 2023 | 134 | 0.180 |
Why?
| | Causality | 1 | 2023 | 128 | 0.180 |
Why?
| | Adult | 13 | 2026 | 40821 | 0.180 |
Why?
| | Anti-Infective Agents | 2 | 2022 | 234 | 0.180 |
Why?
| | State Government | 1 | 2022 | 45 | 0.170 |
Why?
| | Central Nervous System Infections | 1 | 2022 | 34 | 0.170 |
Why?
| | Nervous System Malformations | 1 | 2022 | 46 | 0.170 |
Why?
| | Nutritional Status | 1 | 2024 | 344 | 0.170 |
Why?
| | Case Management | 1 | 2021 | 66 | 0.160 |
Why?
| | Suicide, Attempted | 1 | 2014 | 374 | 0.160 |
Why?
| | Meningitis | 1 | 2022 | 80 | 0.160 |
Why?
| | Alaska Natives | 1 | 2021 | 53 | 0.160 |
Why?
| | Terminal Care | 1 | 2024 | 284 | 0.160 |
Why?
| | Encephalitis | 1 | 2022 | 142 | 0.150 |
Why?
| | Hospital Mortality | 2 | 2013 | 1037 | 0.150 |
Why?
| | Cost Savings | 1 | 2019 | 85 | 0.150 |
Why?
| | Antipsychotic Agents | 2 | 2008 | 178 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2025 | 3633 | 0.140 |
Why?
| | Hip Fractures | 1 | 2009 | 88 | 0.140 |
Why?
| | Population Surveillance | 1 | 2022 | 477 | 0.140 |
Why?
| | Length of Stay | 2 | 2013 | 1342 | 0.140 |
Why?
| | Algorithms | 1 | 2026 | 1843 | 0.130 |
Why?
| | Health Facility Closure | 1 | 2018 | 8 | 0.130 |
Why?
| | Economics, Hospital | 1 | 2018 | 28 | 0.130 |
Why?
| | Neoplasm Metastasis | 1 | 2020 | 693 | 0.130 |
Why?
| | Legislation, Food | 1 | 2017 | 1 | 0.130 |
Why?
| | Trans Fatty Acids | 1 | 2017 | 5 | 0.130 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 926 | 0.130 |
Why?
| | Independent Living | 1 | 2018 | 114 | 0.130 |
Why?
| | Longitudinal Studies | 1 | 2025 | 3005 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2025 | 870 | 0.120 |
Why?
| | Pregnancy | 3 | 2025 | 7217 | 0.120 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 502 | 0.120 |
Why?
| | Health Services Accessibility | 3 | 2022 | 1101 | 0.110 |
Why?
| | Smoking Cessation | 1 | 2019 | 440 | 0.110 |
Why?
| | Poverty | 1 | 2019 | 530 | 0.110 |
Why?
| | Residence Characteristics | 1 | 2018 | 385 | 0.110 |
Why?
| | Awareness | 1 | 2016 | 113 | 0.110 |
Why?
| | Motivation | 1 | 2019 | 601 | 0.110 |
Why?
| | Drug Monitoring | 1 | 2008 | 399 | 0.110 |
Why?
| | Asthma | 1 | 2026 | 1800 | 0.100 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2015 | 97 | 0.100 |
Why?
| | Health Care Surveys | 1 | 2016 | 538 | 0.100 |
Why?
| | Frail Elderly | 1 | 2015 | 136 | 0.100 |
Why?
| | Patient Compliance | 1 | 2007 | 587 | 0.100 |
Why?
| | Patient-Centered Care | 1 | 2018 | 551 | 0.100 |
Why?
| | Physicians | 1 | 2022 | 954 | 0.100 |
Why?
| | Adolescent | 4 | 2026 | 22451 | 0.100 |
Why?
| | Needs Assessment | 1 | 2016 | 403 | 0.100 |
Why?
| | Data Collection | 1 | 2016 | 647 | 0.090 |
Why?
| | Qualitative Research | 2 | 2022 | 1720 | 0.090 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 1101 | 0.090 |
Why?
| | Logistic Models | 3 | 2013 | 2112 | 0.090 |
Why?
| | Health Personnel | 1 | 2017 | 750 | 0.080 |
Why?
| | Incidence | 3 | 2014 | 2910 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2015 | 692 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 2017 | 1212 | 0.070 |
Why?
| | Sex Factors | 2 | 2026 | 2101 | 0.070 |
Why?
| | Drug Prescriptions | 2 | 2008 | 290 | 0.060 |
Why?
| | Outpatients | 2 | 2011 | 437 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2026 | 2910 | 0.060 |
Why?
| | Comorbidity | 2 | 2011 | 1652 | 0.050 |
Why?
| | Aging | 1 | 2016 | 1983 | 0.050 |
Why?
| | Child | 4 | 2026 | 22638 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 5875 | 0.050 |
Why?
| | Death | 1 | 2023 | 129 | 0.040 |
Why?
| | United States Indian Health Service | 1 | 2022 | 40 | 0.040 |
Why?
| | Subacute Care | 1 | 2023 | 84 | 0.040 |
Why?
| | Morbidity | 1 | 2022 | 317 | 0.040 |
Why?
| | Pharmaceutical Services | 1 | 2021 | 76 | 0.040 |
Why?
| | Schools | 1 | 2024 | 436 | 0.040 |
Why?
| | Age Distribution | 1 | 2011 | 395 | 0.040 |
Why?
| | Sex Distribution | 1 | 2011 | 379 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2011 | 130 | 0.040 |
Why?
| | Observation | 1 | 2009 | 51 | 0.040 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2009 | 33 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2026 | 1754 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2020 | 137 | 0.040 |
Why?
| | Respiratory Insufficiency | 1 | 2013 | 330 | 0.040 |
Why?
| | Diphosphonates | 1 | 2009 | 67 | 0.040 |
Why?
| | Bone Density Conservation Agents | 1 | 2009 | 82 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 2011 | 187 | 0.040 |
Why?
| | Drug Utilization | 1 | 2009 | 170 | 0.030 |
Why?
| | Estrogen Replacement Therapy | 1 | 2009 | 144 | 0.030 |
Why?
| | Infant | 2 | 2024 | 10093 | 0.030 |
Why?
| | Documentation | 1 | 2020 | 202 | 0.030 |
Why?
| | Mortality | 1 | 2011 | 375 | 0.030 |
Why?
| | Odds Ratio | 1 | 2011 | 1070 | 0.030 |
Why?
| | Disease Management | 1 | 2022 | 649 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2021 | 11744 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1318 | 0.030 |
Why?
| | Models, Biological | 1 | 2014 | 1758 | 0.030 |
Why?
| | New York | 1 | 2017 | 127 | 0.030 |
Why?
| | Telemedicine | 1 | 2026 | 956 | 0.030 |
Why?
| | Inpatients | 1 | 2011 | 538 | 0.030 |
Why?
| | Body Weight | 1 | 2020 | 964 | 0.030 |
Why?
| | Sepsis | 1 | 2013 | 668 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2021 | 769 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2008 | 959 | 0.030 |
Why?
| | Risk | 1 | 2008 | 917 | 0.030 |
Why?
| | Age Factors | 1 | 2013 | 3321 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 945 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 994 | 0.030 |
Why?
| | Consumer Behavior | 1 | 2015 | 68 | 0.030 |
Why?
| | Communication | 1 | 2021 | 979 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2026 | 2357 | 0.030 |
Why?
| | Time Factors | 1 | 2014 | 7079 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 6050 | 0.020 |
Why?
| | Child, Preschool | 1 | 2026 | 11888 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1935 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6449 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 8087 | 0.020 |
Why?
|
|
Perraillon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|